![Zafrira Avnur](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zafrira Avnur
Director/Board Member at
CathWorks Ltd.
Profile
Zafrira Avnur is currently a Director at CalciMedica, Inc. (US), PhysIQ, Inc., Raziel Therapeutics RT Ltd., Lyndra Therapeutics, Inc., CathWorks Ltd., Enclear Therapies, Inc., Volastra Therapeutics, Inc., Nemdx, Inc., and a Partner at Quark Venture, Inc. She previously worked as a Director at Microbion Corp., Biscayne Neurotherapeutics, Inc., Eloxx Pharmaceuticals Ltd., Keros Therapeutics, Inc., and Pi Therapeutics Ltd. She was also an Independent Director at Eloxx Pharmaceuticals, Inc. from 2017 to 2022.
From 2009 to 2016, she was the Head-Academic Innovation at F.
Hoffmann-La Roche Ltd. Dr. Avnur received her undergraduate and graduate degrees from Ben-Gurion University of the Negev and her doctorate from Weizmann Institute of Science.
Zafrira Avnur active positions
| Companies | Position | Start |
|---|---|---|
Lyndra Therapeutics, Inc.
 Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Develops oral drug delivery platform | Director/Board Member | - |
PhysIQ, Inc.
 PhysIQ, Inc. Packaged SoftwareTechnology Services Provides proprietary predictive analytics for human physiology | Director/Board Member | 26/07/2017 |
CathWorks Ltd.
 CathWorks Ltd. Medical SpecialtiesHealth Technology Develops AI-powered imaging platform that derives blood-flow physiology from standard coronary angiograms which helps clinicians for diagnostic and treatment decisions in coronary artery disease | Director/Board Member | - |
Enclear Therapies, Inc.
 Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel device-based therapies to treat patients | Director/Board Member | 19/02/2020 |
Raziel Therapeutics RT Ltd.
 Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative technology to treat obesity disease | Director/Board Member | 10/12/2019 |
Volastra Therapeutics, Inc.
 Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics | Director/Board Member | - |
CalciMedica Subsidiary, Inc.
 CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Director/Board Member | 11/03/2021 |
20/20 HealthCare Partners LLC
 20/20 HealthCare Partners LLC Investment ManagersFinance 20/20 Healthcare Partners Invests in private companies located in the United States. The firm focuses on diagnostic imaging, medical devices, healthcare IT, biotechnology and pharmaceuticals. It participates in early stage transactions. It acts as lead investor. | Consultant / Advisor | - |
Quark Venture, Inc.
 Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc invests in companies located globally. The firm targets companies operating in the fields of innovative biotechnology and health sciences. It provides financing in the form of equity. | Private Equity Investor | 01/10/2016 |
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Zafrira Avnur
| Companies | Position | End |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Zafrira Avnur
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
40
1st degree connections
20
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Microbion Corp.
 Microbion Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage pharmaceutical company | Health Technology |
CalciMedica Subsidiary, Inc.
CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Health Technology |
PhysIQ, Inc.
PhysIQ, Inc. Packaged SoftwareTechnology Services Provides proprietary predictive analytics for human physiology | Technology Services |
SQZ Biotechnologies Co.
 SQZ Biotechnologies Co. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cell therapies for patients with cancer, infectious diseases and serious conditions | Health Technology |
Ben-Gurion University of the Negev
 Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
20/20 HealthCare Partners LLC
20/20 HealthCare Partners LLC Investment ManagersFinance 20/20 Healthcare Partners Invests in private companies located in the United States. The firm focuses on diagnostic imaging, medical devices, healthcare IT, biotechnology and pharmaceuticals. It participates in early stage transactions. It acts as lead investor. | Finance |
Biscayne Neurotherapeutics, Inc.
 Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for epilepsy, pain and other central nervous system disorders | Health Technology |
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel genetic therapies | Health Technology |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Develops innovative technology to treat obesity disease | Health Technology |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Develops oral drug delivery platform | Technology Services |
Keros Therapeutics, Inc.
 Keros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics for muscle diseases | Health Technology |
CathWorks Ltd.
CathWorks Ltd. Medical SpecialtiesHealth Technology Develops AI-powered imaging platform that derives blood-flow physiology from standard coronary angiograms which helps clinicians for diagnostic and treatment decisions in coronary artery disease | Health Technology |
Pi Therapeutics Ltd.
 Pi Therapeutics Ltd. BiotechnologyHealth Technology Develops a proprietary cancer drug | Health Technology |
Quark Venture, Inc.
Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc invests in companies located globally. The firm targets companies operating in the fields of innovative biotechnology and health sciences. It provides financing in the form of equity. | Finance |
Eloxx Pharmaceuticals, Inc.
 Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
Enclear Therapies, Inc.
Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel device-based therapies to treat patients | Health Technology |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in discovery and development of oncology therapeutics | Health Technology |
Nemdx, Inc.
 Nemdx, Inc. Packaged SoftwareTechnology Services Develops medical diagnostic platform intended to reveal critical information on protein function in neurodegenerative diseases | Technology Services |
- Stock Market
- Insiders
- Zafrira Avnur
